Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
Published on: October 6, 2023
Mortality following snake bite envenomation by Bitis arietans in an HIV positive child: A case report
Gregory B Firth1, Matthew Street, Yammesh Ramguthy
1Department of Orthopedic Surgery, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg Department of Intensive Care and Pediatric Department, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Insights
This case report details a fatal snake bite in a South African child with human immunodeficiency virus (HIV). Delayed treatment and HIV exacerbated envenomation, leading to sepsis and death, underscoring the need for prompt snake bite protocols.
Area of Science:
- Pediatric Toxicology
- Infectious Diseases
- Dermatology
Background:
- Snake bites are a significant public health concern in rural South Africa.
- Hospitals must maintain preparedness for uncommon snake bite presentations.
- This study documents the first reported case of human immunodeficiency virus (HIV) interaction with snake bite in South African children.
Observation:
- A 1-year-old child presented with cytotoxic envenomation and compartment syndrome in the left upper limb following a snake bite.
- Delayed polyvalent antivenom administration (4 days) and a concurrent HIV diagnosis complicated the clinical course.
- The patient developed extensive skin necrosis, persistent thrombocytopenia, and ultimately succumbed to overwhelming sepsis.
Findings:
- The case highlights the complex interplay between snake venom toxicity and HIV infection in a pediatric patient.
- Persistent thrombocytopenia was observed, potentially attributed to both HIV and snake bite envenomation.
- Delayed treatment significantly worsened the patient's prognosis, leading to severe local and systemic complications.
Implications:
- Effective management protocols for snake bites are crucial in all healthcare settings, especially in regions with high incidence.
- This case emphasizes the heightened risk and challenges in treating snake bites in immunocompromised children, particularly those with HIV.
- Further research into the synergistic effects of envenomation and HIV on hematological parameters is warranted.
Abstract:
Snake bites occur commonly in the rural areas of South Africa. Hospitals where snake bites are uncommon should always have protocols on standby in the event of such cases presenting. This is the first reported case documenting the effect of human immunodeficiency virus (HIV) on snake bite in South African children.A case report and review of relevant information about the case was undertaken.We present a case of a 1-year-old child referred from a peripheral hospital following a snake bite to the left upper limb with a compartment syndrome and features of cytotoxic envenomation. The patient presented late with a wide area of necrotic skin on the arm requiring extensive debridement. The underlying muscle was not necrotic. Polyvalent antivenom (South African Institute of Medical Research Polyvalent Snakebite Antiserum) administration was delayed by 4 days after the snake bite. The patient was also diagnosed with HIV and a persistent thrombocytopenia possibly due to both HIV infection and the snake bite venom. Lower respiratory tract infections with subsequent overwhelming sepsis ultimately resulted in the child's death.The case highlights the challenge of treating a snake bite in a young child with HIV and the detrimental outcome of delayed treatment. A protocol is essential in the management of snake bites in all hospitals.Level IV, Case report.This case highlights the interaction of snake bite envenomation and HIV infection on thrombocytopenia.
More Related Videos
08:02Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection
Published on: July 28, 2022
11:28Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose Herpestes Auropunctatus Sera for Use as an Oral Rabies Vaccination Biological Marker
Published on: May 31, 2019